From: Morphofunctional cardiac changes in singleton and twin pregnancies: a longitudinal cohort study
2nd trimester | 3rd trimester | PP1 | PP2 | |
---|---|---|---|---|
Singleton pregnancies (women tested) | (n = 42) | (n = 42) | (n = 41) | (n = 41) |
Twin pregnancies (women tested) | (n = 18) | (n = 21) | (n = 22) | (n = 22) |
BNP, pg/mL | SP 8.4 (5.2–11.3) | 8.1 (2.9–13.3) | 32.0 (15.1–52.6)* † | 8.0 (3.6–13.4) |
TP 11.0 (5.9–21.4) | 20.6 (10.0–29.6) * | 56.9 (44.4–74.6) *† | 6.1 (2.9–12.2) | |
NT-proBNP, pg/mL | SP 27 (19–52) | 28 (13–49) | 110 (44–218) † | 30 (18–47) |
TP 27 (18–48) | 49 (30–113) * | 180 (102–228) † | 20 (14–48) | |
hs-TnI, pg/mL | SP 0.9 (0.5–1.3) | 1.2 (0.8–1.6) | 1.9 (1.1–3.9) † | 1.3 (1.0–1.6) † |
TP 0.9 (0.2–1.8) | 1.5 (1.0–2.2) | 1.5 (1.3–4.7) † | 0.9 (0.4–1.9) | |
PRA, ng/mL/h | SP 20 (10–36) | 15 (8.4–24) | 3.6 (1.9–8.0) † | 0.9 (0.5–1.8) † |
TP 12 (5.6–20) | 11 (5.1–19) | 1.9 (0.9–5.9) † | 1.3 (0.7–1.5) † | |
PAC, pg/mL | SP 498 (368–747) | 707 (441–1023) | 96 (74.4–195) † | 116 (77.8–161) † |
TP 750 (439–1363) | 503 (365–1435) | 75 (52–104) *† | 102 (58–142) † | |
Serum creatinine, mg/dL | SP 0.47 (0.41–0.51) | 0.49 (0.41–0.56) | 0.55 (0.48–0.59) † | 0.61 (0.54–0.66)v |
TP 0.49 (0.40–0.53) | 0.54 (0.49–0.67) *† | 0.56 (0.49–0.63) † | 0.62 (0.52–0.63) † | |
eGFR, mL/min/1.73m2 | SP 125 (109–138) | 118 (99–140) | 104 (92–120) † | 91 (81–109) † |
TP 120 (110–154) | 103 (86–118) *† | 101 (89–119) † | 92 (89–110) † |